🚨 Mythbuster Monday: Unpacking Drug Pricing and Innovation 🚨

Myth: "Higher drug prices are necessary for pharmaceutical innovation."

Fact: Let's set the record straight! RATH believes that innovation in pharmaceuticals should not come at an unaffordable cost to patients. We support policies that foster innovation while ensuring that medications remain accessible and affordable. By implementing strategic funding, encouraging competitive markets, and supporting public-private partnerships, we can maintain a healthy balance between stimulating pharmaceutical advancements and keeping drug prices reasonable. 💊🔬